oxazoles has been researched along with Cirrhosis, Liver in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 4 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Katsiki, N; Polyzos, SA | 1 |
| Aoyama, K; Erion, DM; Kaneko, M; Matsumoto, M; Nakamura, S; Nambu, T; Nishida, M; Ogino, H; Wang, X; Yashiro, H | 1 |
| Attia, SL; Mouzaki, M; Softic, S | 1 |
| Alkhouri, N; Beck, AH; Bhandari, BR; Borg, BB; Caldwell, SH; Chuang, JC; Chung, C; Ding, D; Elkhashab, M; Ghalib, R; Goodman, Z; Gunn, N; Hassanein, T; Huss, RS; Iyer, R; Jia, C; Kabler, H; Kohli, A; Kowdley, KV; Loomba, R; Myers, RP; Neff, G; Noureddin, M; Patel, K; Poulos, J; Resnick, M; Ruane, P; Sheikh, A; Shiffman, ML; Strasser, S; Subramanian, GM; Wapinski, I; Wong, VW; Younes, Z | 1 |
| Hou, MC; Hsieh, YC; Huang, CC; Huang, SF; Huang, YH; Lee, KC; Li, TH; Lin, HC; Liu, RS; Tsai, HC; Yang, YY | 1 |
| Bennett, M; Charlton, M; Chung, C; Harrison, SA; Harting, E; Kayali, Z; Lai, M; Lawitz, EJ; Loomba, R; McColgan, BJ; Middleton, MS; Myers, RP; Noureddin, M; Ray, AS; Ruane, P; Subramanian, GM; Tarrant, JM; Wang, L | 1 |
| Byrjalsen, I; Christiansen, C; Gardner, S; Goodman, Z; Henriksen, K; Karsdal, MA; Krag, A; Leeming, DJ; Nielsen, MJ; Patel, K; Schuppan, D | 1 |
| Brigandi, R; Chuang, WL; Gardner, S; Goodman, Z; Husa, P; Jonas, M; Levine, R; Makhlouf, H; McHutchison, J; Patel, K; Rockey, D; Rodriguez-Torres, M; Schultz, M; Shiffman, M; Stancil, B; Theodore, D; Watson, H; Webster, A | 1 |
| Bai, YH; Kim, CM; Kim, SY; Park, JH; Park, RY; Rhee, JH; Ryu, PY; Shin, SH; Sun, HY | 1 |
| Ishikawa, A; Misawa, S; Okamura, T; Ono, A; Tanaka, E | 1 |
| Ishikawa, A; Kobayashi, S; Misawa, S; Okamura, T; Ono, A; Tanaka, E; Yasuhara, H | 1 |
| Fishman, AP | 1 |
2 review(s) available for oxazoles and Cirrhosis, Liver
| Article | Year |
|---|---|
Evolving Role for Pharmacotherapy in NAFLD/NASH.
Topics: Adult; Benzhydryl Compounds; Chenodeoxycholic Acid; Child; Clinical Trials, Phase III as Topic; Fibroblast Growth Factors; Glucosides; Humans; Imidazoles; Isobutyrates; Liraglutide; Liver; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease; Oxazoles; Polyethylene Glycols; Pyridazines; Pyrimidines; Severity of Illness Index; Sulfoxides; Treatment Outcome; Uracil | 2021 |
Dietary pulmonary hypertension.
Topics: Amines; Animals; Appetite Depressants; Arterial Occlusive Diseases; Capillaries; Capillary Permeability; Chemical and Drug Induced Liver Injury; Diet; Endothelium; Gastrointestinal Hormones; Humans; Hypertension, Pulmonary; Hypoxia; Liver; Liver Cirrhosis; Lung; Oxazoles; Phenformin; Pulmonary Fibrosis; Pyrrolizidine Alkaloids; Vasodilator Agents | 1974 |
4 trial(s) available for oxazoles and Cirrhosis, Liver
| Article | Year |
|---|---|
Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH.
Topics: Aged; Azetidines; Benzamides; Biomarkers; Biopsy; Drug Administration Schedule; Drug Therapy, Combination; End Stage Liver Disease; Female; Humans; Imidazoles; Isobutyrates; Isonicotinic Acids; Liver; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Oxazoles; Pyridines; Pyrimidines; Severity of Illness Index; Treatment Outcome | 2021 |
GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease.
Topics: Acetyl-CoA Carboxylase; Biomarkers; Carnitine; Double-Blind Method; Elasticity Imaging Techniques; Fatty Liver; Female; Humans; Isobutyrates; Liver Cirrhosis; Magnetic Resonance Imaging; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Oxazoles; Pyrimidines | 2018 |
Fibrogenesis assessed by serological type III collagen formation identifies patients with progressive liver fibrosis and responders to a potential antifibrotic therapy.
Topics: Biomarkers; Collagen Type III; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Oxazoles; Patient Selection; Quinazolines; Thiazolidinediones; Tyrosine | 2016 |
Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infection.
Topics: Adult; Aged; Biopsy; Double-Blind Method; Female; Hepatitis C, Chronic; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Oxazoles; PPAR gamma; Tyrosine | 2010 |
6 other study(ies) available for oxazoles and Cirrhosis, Liver
| Article | Year |
|---|---|
Semaglutide, cilofexor, and firsocostat for nonalcoholic steatohepatitis: a dance that may need more than one dancer.
Topics: Azetidines; Dancing; Glucagon-Like Peptides; Humans; Isobutyrates; Isonicotinic Acids; Liver; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease; Oxazoles; Pyrimidines | 2022 |
Acetyl-CoA carboxylase 1 and 2 inhibition ameliorates steatosis and hepatic fibrosis in a MC4R knockout murine model of nonalcoholic steatohepatitis.
Topics: Acetyl-CoA Carboxylase; Animals; Disease Models, Animal; Enzyme Inhibitors; Gene Knockout Techniques; Isobutyrates; Liver; Liver Cirrhosis; Mice; Non-alcoholic Fatty Liver Disease; Organ Size; Oxazoles; Pyrimidines; Receptor, Melanocortin, Type 4; Triglycerides | 2020 |
Beneficial Effects of the Peroxisome Proliferator-Activated Receptor α/γ Agonist Aleglitazar on Progressive Hepatic and Splanchnic Abnormalities in Cirrhotic Rats with Portal Hypertension.
Topics: Animals; Caco-2 Cells; Humans; Hypertension, Portal; Liver Circulation; Liver Cirrhosis; Male; Neovascularization, Pathologic; Oxazoles; PPAR alpha; PPAR gamma; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Thiophenes | 2018 |
Vibrio vulnificus vulnibactin, but not metalloprotease VvpE, is essentially required for iron-uptake from human holotransferrin.
Topics: Amides; Culture Media; DNA Primers; Electrophoresis, Polyacrylamide Gel; Gene Deletion; Humans; Indicators and Reagents; Iron; Liver Cirrhosis; Metalloproteases; Mutagenesis, Insertional; Mutation; Oxazoles; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Transferrin; Vibrio vulnificus | 2006 |
Trimethadione metabolism in patients with normal liver and in patients with chronic liver disease.
Topics: Carcinoma, Hepatocellular; Chronic Disease; Dimethadione; Female; Humans; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Oxazoles; Trimethadione | 1987 |
Trimethadione tolerance test for evaluation of functional reserve of the liver in patients with liver cirrhosis and esophageal varices.
Topics: Adult; Dimethadione; Esophageal and Gastric Varices; Female; Humans; Kinetics; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Oxazoles; Trimethadione | 1986 |